ID

31395

Beskrivning

Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00438607

Länk

https://clinicaltrials.gov/show/NCT00438607

Nyckelord

  1. 2018-08-19 2018-08-19 -
Rättsinnehavare

See clinicaltrials.gov

Uppladdad den

19 augusti 2018

DOI

För en begäran logga in.

Licens

Creative Commons BY 4.0

Modellkommentarer :

Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.

Itemgroup-kommentar för :

Item-kommentar för :

Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.

Eligibility Parkinson's Disease NCT00438607

Eligibility Parkinson's Disease NCT00438607

Inclusion Criteria
Beskrivning

Inclusion Criteria

Alias
UMLS CUI
C1512693
must carry a diagnosis of idiopathic pd according to uk parkinson's disease society brain bank clinical diagnostic criteria, and be hoehn & yahr stage ii to iv (inclusive) when off.
Beskrivning

Parkinson Disease Hoehn and Yahr Stage

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0030567
UMLS CUI [1,2]
C3639483
must be on a stable dose of l-3,4-dihydroxyphenylalanine (l-dopa)/carbidopa or l-dopa/benserazide for at least 4 weeks prior to enrollment.
Beskrivning

Carbidopa / Levodopa Dose Stable | Benserazide / Levodopa Dose Stable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0353697
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
UMLS CUI [2,1]
C0358787
UMLS CUI [2,2]
C0178602
UMLS CUI [2,3]
C0205360
except for l-dopa and certain allowed dopamine agonists, must not be receiving any other pd medications. (current treatment with certain dopamine agonists is allowed but subjects must have been on a stable dose for at least 4 weeks prior to enrollment).
Beskrivning

Other Antiparkinson Agents Absent | Exception Levodopa | Exception Dopamine Agonists allowed | Dopamine Agonists Dose Stable

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1579414
UMLS CUI [1,2]
C0332197
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0023570
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C0178601
UMLS CUI [3,3]
C0683607
UMLS CUI [4,1]
C0178601
UMLS CUI [4,2]
C0178602
UMLS CUI [4,3]
C0205360
some subjects must demonstrate a definite end of l-dopa dose wearing off (at least 2 hours off time per waking day) and must be able to keep accurate patient diaries of pd activity.
Beskrivning

Levodopa Dose Wearing off effect Discontinued | Subject Diary Parkinson Disease Completion

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0023570
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C1504539
UMLS CUI [1,4]
C1444662
UMLS CUI [2,1]
C3890583
UMLS CUI [2,2]
C0030567
UMLS CUI [2,3]
C0205197
major exclusion criteria:
Beskrivning

Exclusion Criteria Major

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C0205164
a mini mental state examination (mmse) score <26.
Beskrivning

Mini-mental state examination

Datatyp

boolean

Alias
UMLS CUI [1]
C0451306
history or clinical features consistent with an atypical parkinsonian syndrome.
Beskrivning

Feature Clinical Consistent with Atypical Parkinson Disease

Datatyp

boolean

Alias
UMLS CUI [1,1]
C2348519
UMLS CUI [1,2]
C0205210
UMLS CUI [1,3]
C0332290
UMLS CUI [1,4]
C1868596
any significant non-parkinson's central nervous system disorder.
Beskrivning

CNS disorder | Exception Parkinson Disease

Datatyp

boolean

Alias
UMLS CUI [1]
C0007682
UMLS CUI [2,1]
C1705847
UMLS CUI [2,2]
C0030567
any significant axis i psychiatric disease from the diagnostic and statistical manual of mental disorders (dsm).
Beskrivning

Axis I diagnosis

Datatyp

boolean

Alias
UMLS CUI [1]
C0270287
any previous surgical intervention for parkinson's disease.
Beskrivning

Operative Surgical Procedures Parkinson Disease

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C0030567
history of certain malignancies.
Beskrivning

Malignant Neoplasms

Datatyp

boolean

Alias
UMLS CUI [1]
C0006826
history of severe allergic anaphylactic reactions to any drug.
Beskrivning

Anaphylaxis Severe Pharmaceutical Preparations

Datatyp

boolean

Alias
UMLS CUI [1,1]
C0002792
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0013227
clinically significant baseline electrocardiogram (ecg).
Beskrivning

Electrocardiography Clinical Significance

Datatyp

boolean

Alias
UMLS CUI [1,1]
C1623258
UMLS CUI [1,2]
C2826293
orthostatic hypotension.
Beskrivning

Hypotension, Orthostatic

Datatyp

boolean

Alias
UMLS CUI [1]
C0020651
hba1c >7.0%
Beskrivning

Hemoglobin A1c measurement

Datatyp

boolean

Alias
UMLS CUI [1]
C0474680

Similar models

Eligibility Parkinson's Disease NCT00438607

Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Item Group
C1512693 (UMLS CUI)
Parkinson Disease Hoehn and Yahr Stage
Item
must carry a diagnosis of idiopathic pd according to uk parkinson's disease society brain bank clinical diagnostic criteria, and be hoehn & yahr stage ii to iv (inclusive) when off.
boolean
C0030567 (UMLS CUI [1,1])
C3639483 (UMLS CUI [1,2])
Carbidopa / Levodopa Dose Stable | Benserazide / Levodopa Dose Stable
Item
must be on a stable dose of l-3,4-dihydroxyphenylalanine (l-dopa)/carbidopa or l-dopa/benserazide for at least 4 weeks prior to enrollment.
boolean
C0353697 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
C0358787 (UMLS CUI [2,1])
C0178602 (UMLS CUI [2,2])
C0205360 (UMLS CUI [2,3])
Other Antiparkinson Agents Absent | Exception Levodopa | Exception Dopamine Agonists allowed | Dopamine Agonists Dose Stable
Item
except for l-dopa and certain allowed dopamine agonists, must not be receiving any other pd medications. (current treatment with certain dopamine agonists is allowed but subjects must have been on a stable dose for at least 4 weeks prior to enrollment).
boolean
C1579414 (UMLS CUI [1,1])
C0332197 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0023570 (UMLS CUI [2,2])
C1705847 (UMLS CUI [3,1])
C0178601 (UMLS CUI [3,2])
C0683607 (UMLS CUI [3,3])
C0178601 (UMLS CUI [4,1])
C0178602 (UMLS CUI [4,2])
C0205360 (UMLS CUI [4,3])
Levodopa Dose Wearing off effect Discontinued | Subject Diary Parkinson Disease Completion
Item
some subjects must demonstrate a definite end of l-dopa dose wearing off (at least 2 hours off time per waking day) and must be able to keep accurate patient diaries of pd activity.
boolean
C0023570 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C1504539 (UMLS CUI [1,3])
C1444662 (UMLS CUI [1,4])
C3890583 (UMLS CUI [2,1])
C0030567 (UMLS CUI [2,2])
C0205197 (UMLS CUI [2,3])
Exclusion Criteria Major
Item
major exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
Mini-mental state examination
Item
a mini mental state examination (mmse) score <26.
boolean
C0451306 (UMLS CUI [1])
Feature Clinical Consistent with Atypical Parkinson Disease
Item
history or clinical features consistent with an atypical parkinsonian syndrome.
boolean
C2348519 (UMLS CUI [1,1])
C0205210 (UMLS CUI [1,2])
C0332290 (UMLS CUI [1,3])
C1868596 (UMLS CUI [1,4])
CNS disorder | Exception Parkinson Disease
Item
any significant non-parkinson's central nervous system disorder.
boolean
C0007682 (UMLS CUI [1])
C1705847 (UMLS CUI [2,1])
C0030567 (UMLS CUI [2,2])
Axis I diagnosis
Item
any significant axis i psychiatric disease from the diagnostic and statistical manual of mental disorders (dsm).
boolean
C0270287 (UMLS CUI [1])
Operative Surgical Procedures Parkinson Disease
Item
any previous surgical intervention for parkinson's disease.
boolean
C0543467 (UMLS CUI [1,1])
C0030567 (UMLS CUI [1,2])
Malignant Neoplasms
Item
history of certain malignancies.
boolean
C0006826 (UMLS CUI [1])
Anaphylaxis Severe Pharmaceutical Preparations
Item
history of severe allergic anaphylactic reactions to any drug.
boolean
C0002792 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0013227 (UMLS CUI [1,3])
Electrocardiography Clinical Significance
Item
clinically significant baseline electrocardiogram (ecg).
boolean
C1623258 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Hypotension, Orthostatic
Item
orthostatic hypotension.
boolean
C0020651 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hba1c >7.0%
boolean
C0474680 (UMLS CUI [1])

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial